Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;10(3):301-314.
doi: 10.3233/JND-230001.

Psychometric Characteristics of the Motor Function Measure in Neuromuscular Diseases: A Systematic Review1

Shams Ribault  1   2 , Pascal Rippert  1   3 , Minal Jain  4 , Laure Le Goff  1 , Dominique Vincent Genod  1 , Aurélie Barriere  1 , Anne Berruyer  1 , Camille Garde  1 , Marie Tinat  1 , Christelle Pons  5 , Carole Vuillerot  1   2
Affiliations

Psychometric Characteristics of the Motor Function Measure in Neuromuscular Diseases: A Systematic Review1

Shams Ribault et al. J Neuromuscul Dis. 2023.

Abstract

Background: Recent pharmaceutical breakthroughs in neuromuscular diseases may considerably change the prognosis and natural history these diseases. The ability to measure clinically relevant outcomes such as motor function is critical for the assessment of therapeutics and the follow up of individuals. The Motor Function Measure (MFM) is a quantitative scale designed to measure motor function in adult and children with neuromuscular disease (NMD).

Objective: The objective of this study is to assess the quality and level of evidence of the MFM's published measurement properties by completing a systematic review of the validation and responsiveness studies of the MFM20 (a 20-item version of MFM adapted for children 2 to 6 years of age) and the MFM32 (the original 32 item version), in all NMDs and in specific diseases.

Methods: A search for MFM responsiveness and MFM validation studies was completed in February 2023 in EMBASE, MEDLINE, SCOPUS and Web of Science databases. The PRISMA guidelines and the COSMIN manual for systematic reviews were followed for databases searches, articles screening and selection, study quality and measurement properties evaluation.

Results: 49 studies were included in analysis. In studies including individuals with all NMDs, MFM's internal consistency, reliability, convergent validity, construct validity and responsiveness were rated as sufficient with a high quality of evidence. Structural validity was rated sufficient with a moderate quality of evidence In SMA in particular, MFM's reliability, internal consistency, convergent validity, discriminant validity and responsiveness are sufficient with a high quality of evidence. More studies would be required to assess specific measurement properties in different diseases. MFM32's minimal clinically relevant difference has been defined between 2 and 6%.

Conclusion: MFM's structural validity, internal consistency, reliability, construct validity, convergent validity and responsiveness have been verified with moderate to high level of evidence.

Keywords: Outcome assessment; natural history; neuromuscular diseases; systematic review; validation study.

PubMed Disclaimer

Conflict of interest statement

CONFLICTSOFINTEREST

The authors have no conflict of interest to report.

Figures

Fig. 1.
Fig. 1.
PRISMA 2020 flow diagram for new systematic reviews which included searches of datebases, registers and other sources.
See this image and copyright information in PMC

References

    1. Schorling DC, Pechmann A, Kirschner J. Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care. J Neuromuscul Dis. 2020;7(1):1–13. - PMC - PubMed
    1. Mazzone E, De Sanctis R, Fanelli L, Bianco F, Main M, van den Hauwe M, et al. Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients. Neuromuscul Disord NMD. 2014;24(4):347–52. - PubMed
    1. Glanzman AM, O’Hagen JM, McDermott MP, Martens WB, Flickinger J, Riley S, et al. Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol. 2011;26(12):1499–507. - PubMed
    1. Mazzone E, Martinelli D, Berardinelli A, Messina S, D’Amico A, Vasco G, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord NMD. 2010;20(11):712–6. - PubMed
    1. Vignos PJ, Archibald KC. Maintenance of ambulation in childhood muscular dystrophy. J Chronic Dis. 1960;12:273–90. - PubMed

Publication types